| Serial Number | 90263172 |
| Word Mark | CEDLARA |
| Filing Date | Monday, October 19, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 15, 2022 |
| Registration Number | 6647940 |
| Registration Date | Tuesday, February 15, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 27, 2021 |
| Goods and Services | Pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others of new therapeutic entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither new chemical entities (NCEs) nor generics and new chemical entities (NCEs) and biologic license application (BLAs) as novel pharmaceutical treatments; research and development in the field of new therapeutic entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither new chemical entities (NCEs) nor generics and new chemical entities (NCEs) and biologic license application (BLAs) as novel pharmaceutical treatments; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; clinical trials services for others; all of the foregoing related to celiac disease |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, December 6, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, July 31, 2020 |
| First Use In Commerce Date | Friday, July 31, 2020 |
| Party Name | 9 Meters Biopharma, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Raleigh, NC 27615 |
| Party Name | 9 Meters Biopharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Raleigh, NC 27615 |
| Party Name | 9 Meters Biopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Raleigh, NC 27615 |
| Event Date | Event Description |
| Friday, June 30, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 30, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, June 30, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, April 26, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, February 15, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 11, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, January 10, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Sunday, January 9, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, December 17, 2021 | USE AMENDMENT FILED |
| Sunday, January 9, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, December 17, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, June 22, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 27, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 27, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 7, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, March 24, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 24, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 24, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 24, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 24, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 18, 2021 | ASSIGNED TO EXAMINER |
| Sunday, December 6, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 22, 2020 | NEW APPLICATION ENTERED |